KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,003 | -28.7% | 414 | -8.6% | 0.04% | -25.9% |
Q2 2023 | $98,233 | +8.8% | 453 | -8.9% | 0.06% | +16.0% |
Q1 2023 | $90,275 | -32.9% | 497 | -27.4% | 0.05% | -28.6% |
Q4 2022 | $134,603 | -43.0% | 685 | -34.8% | 0.07% | -25.5% |
Q3 2022 | $236,000 | +77.4% | 1,050 | +0.2% | 0.09% | +91.8% |
Q2 2022 | $133,000 | -23.1% | 1,048 | -23.3% | 0.05% | -36.4% |
Q1 2022 | $173,000 | -8.9% | 1,367 | -5.8% | 0.08% | +6.9% |
Q4 2021 | $190,000 | -5.5% | 1,451 | -11.7% | 0.07% | -18.2% |
Q3 2021 | $201,000 | +2.0% | 1,644 | -4.9% | 0.09% | +8.6% |
Q2 2021 | $197,000 | -48.6% | 1,728 | -45.8% | 0.08% | -50.0% |
Q1 2021 | $383,000 | +20.8% | 3,186 | +2.0% | 0.16% | +22.7% |
Q4 2020 | $317,000 | +23.3% | 3,122 | -6.0% | 0.13% | -2.2% |
Q3 2020 | $257,000 | -38.8% | 3,322 | -11.8% | 0.14% | -32.2% |
Q2 2020 | $420,000 | +5.8% | 3,766 | -31.7% | 0.20% | +22.1% |
Q1 2020 | $397,000 | -16.4% | 5,516 | -12.5% | 0.16% | +109.0% |
Q4 2019 | $475,000 | – | 6,306 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |